Uncategorized Eli Lilly (LLY) Retains $1,100 Price Target at Bernstein Ahead of Diabetes Conference Post Content
Uncategorized Daktronics Amends JPMorgan Credit Deal, Reincorporates in Delaware for Legal Flexibility Post Content
Uncategorized Oppenheimer Hikes Ascendis Pharma Price Target on Strong Yorvipath Demand Outlook Post Content
Uncategorized Global Markets Gain But Energy, Gold Prices Fall as Israel-Iran Agree to Cease-Fire Post Content
Uncategorized Piper Sandler Reaffirms Overweight Rating on BridgeBio Ahead of Phase 3 CALIBRATE Results Post Content